Trials / Completed
CompletedNCT00556673
Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma
An Exploratory, Multi-centre, Double-blind, Placebocontrolled Crossover Study, to Investigate the Bronchodilatory Efficacy of a Single Dose of Indacaterol in Fixed Combination With Mometasone Furoate Delivered Via a MDDPI (Twisthaler®) in Adult Patients With Persistent Asthma Using Open Label Seretide® Accuhaler® (50/250 Mcg b.i.d.) as an Active Control
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the bronchodilatory efficacy of indacaterol maleate 500 μg/mometasone furoate 400 μg via the Twisthaler® device in adult patients with persistent asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | indacaterol maleate/mometasone furoate | Indacaterol maleate 250 μg / mometasone furoate 200 μg delivered via the Twisthaler device. |
| DRUG | placebo to indacaterol maleate/mometasone furoate | Placebo to indacaterol maleate/mometasone furoate delivered via the Twisthaler device. |
| DRUG | fluticasone proprionate / salmeterol xinafoate | Fluticasone proprionate 250 μg / salmeterol xinafoate 50 μg delivered via the Accuhaler® device. |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-11-12
- Last updated
- 2013-04-22
- Results posted
- 2013-04-22
Locations
2 sites across 2 countries: France, Germany
Source: ClinicalTrials.gov record NCT00556673. Inclusion in this directory is not an endorsement.